DF/HCC Calendar
Allan Halpern, MD, Memorial Sloan Kettering Cancer Center, Department of Dermatology
Please remember that the lecture takes place in the Simches Conference Center 185 Cambridge Street, 3rd floor, Room 3110 from 9am-10am. This is a locked facility and requires a Partners or Harvard ID for entrance. Please contact me advance of the lecture if you need access.
Speaker: Talmadge E. King, Jr., MD
Julius R. Krevans Distinguished Professorship in Internal Medicine
Chair, Department of Medicine
University of California, San Francisco
The Howard, Dorsey, Still Lecture is named for the first three African Americans who graduated from Harvard Medical School in the mid-1800s, and recognizes individuals who have made significant contributions to advancing the nation's health.
Speaker: Claudyne Wilder
Organizational Consultant, Wilder Presentations
CME available
This workshop provides participants with the tools and job aids they need to more effectively make their point to an audience. Specific words, voice tones, and body gestures are discussed to show the participants how one behavior can interfere with and/or move forward positive communication.
Co-sponsored by CFHUF; Harvard Catalyst PFDD; DCP/HMS
Beth Israel Deaconess Medical Center, Hematology/Oncology Grand Rounds
Speaker: Joan Schiller, MD, Chief, Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX
Presentation: "Updates in the Treatment of Non-small Cell Lung Cancer"
HSCI Stem Cell Symposium
Friday, November 6, 2009
Harvard Club of Boston
Click here for the event's website and link to registration (includes a scientific poster session)
November 6‑8, 2009
Dana‑Farber Cancer Institute, Boston, Massachusetts
Offered by: Dana‑Farber Cancer Institute
Course Director: Kenneth D. Miller, MD
Co‑Directors Larissa Nekhlyudov, MD, MPH and Richard Boyajian, NP
| NOVEMBER 6, 2009 | |
|---|---|
| MORNING SESSION: THE EMOTIONAL JOURNEY OF SURVIVORSHIP Moderator: Kenneth D. Miller, MD | |
| 8:30 | Opening Remarks Kenneth D. Miller, MD |
| 8:45 | Seasons of Survivorship Kenneth D. Miller, MD |
| 9:15 | The Emotional Journey of Survivorship‑An Overview Harriet K. Berman, PhD |
| 9:455 | Fear of Recurrence Amy Grose, LICSW |
| 10:15 | Coffee Break |
| 10:30 | Children of Cancer Survivors Vaughn Mankey, MD |
| 11:00 | “We’re in this Together” Co‑Survivors: Spouses and Partners of Cancer Survivors Jane Bausch, LICSW |
| 11:30 | Panel Discussion: The Emotional Journey of Survivorship Amy Grose, LICSW |
| 12:00 | Q&A Session |
| 12:30 | Lunch ‑ On your own |
| AFTERNOON SESSION: CAN WE REDUCE THE RISK OF SECOND CANCERS? Moderator: Julie Silver, MD | |
| 1:30 | Exercise and Cancer Jennifer Ligibel, MD |
| 2:00 | Fighting Cancer with a Fork: Nutrition and Cancer Jeffrey Meyerhardt, MD, MPH |
| 2:30 | Smoking and Smoking Cessation Elyse Park, PhD, MPH |
| 3:00 | Coffee Break |
| 3:15 | Second and Secondary Cancers Andrea Ng, MD, MPH |
| 3:45 | Cancer Rehabilitation Julie Silver, MD |
| 4:15 | Panel Discussion: Lifestyle in Cancer Survivorship Julie Silver, MD |
| 4:45 | Q&A Session |
| 5:00 | Dinner ‑ On your own / Optional Poster Session |
| EVENING SESSION: PRIMARY CARE SYMPOSIUM Moderator: Larissa Nekhlyudov, MD, MPH | |
| 6:30 | Who Will Care for Cancer Survivors? Lawrence N. Shulman, MD |
| 7:15 | What Is Optimal Care for Cancer Survivors: Primary Care, Oncologists, or Both? Larissa Nekhlyudov, MD, MPH |
| 7:45 | The Nuts and Bolts Approach to Survivorship Care: Richard Boyajian, NP Risk Assessment and Care Planning Karen Sommer, NP Psychosocial Counseling Amy Grose, LICSW Nutrition Counseling Stephanie Meyers, MS, RD, LDN |
| 9:00 | Q&A Session |
| NOVEMBER 7, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR WOMEN Moderator: Ann Partridge, MD, MPH | |
| 8:30 | Sexuality and Intimacy Jennifer Potter, MD |
| 9:00 | Endocrine Issues,Menopause, and Bone Health Jean Mulder, MD |
| 9:30 | Screening after Cancer ‑ Compliance Concerns Susan E. Pories, MD, FACS |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| 10:30 | Gynecologic Issues Sandy Falk, MD |
| 11:00 | Special Survivorship Concerns for Women with Breast Cancer Ann Partridge, MD, MPH |
| 11:30 | Panel Discussion: Women and Survivorship Ann Partridge, MD, MPH |
| 12:00 | Q&A Session |
| 12:15 | Lunch ‑ On your own |
| AFTERNOON SESSION: KEEPING CANCER SURVIVORS HEALTHY Moderator: Lawrence N. Shulman, MD | |
| 1:15 | Medical Issues for Adult Survivors of Childhood Cancer Lisa Diller, MD |
| 1:45 | Pulmonary Issues for Cancer Survivors Gerald Weinhouse, MD |
| 2:15 | Renal Issues after Cancer Therapy Benjamin D. Humphreys, MD, PhD |
| 2:45 | Q&A Session |
| 3:00 | Coffee Break |
| 3:15 | Cardiac Issues for Cancer Survivors Javid Moslehi, MD |
| 3:45 | Oral Health Issues Nathaniel S. Treister, DMD, DMSc |
| 4:15 | Panel Discussion: Keeping Cancer Survivors Healthy Lawrence N. Shulman, MD |
| 4:45 | Q&A Session |
| NOVEMBER 8, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR MEN Moderator: Kenneth D. Miller, MD | |
| 8:30 | Sexual Health for Men after Cancer William Conners, MD |
| 9:00 | Depression and Anxiety in Men after Cancer Frank McCaffrey, LICSW, OSW‑C |
| 9:30 | A Panel of Men Who Are Cancer Survivors Frank McCaffrey, LICSW, OSW‑C |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| MINI‑SEMINAR: MEDICAL ISSUES IN SURVIVORSHIP: MORE ON KEEPING CANCER SURVIVORS HEALTHY Moderator: Kenneth D. Miller, MD | |
| 10:30 | Cognitive Problems “Chemobrain” Mary‑Ellen Meadows, PhD |
| 11:00 | Neurologic Problems Patrick Wen, MD |
| 11:30 | Dermatologic Problems Arturo Saavedra, MD, PhD, MBA |
| 12:00 | Pain and Symptom Management in Cancer Survivors Jane deLima Thomas, MD |
| 12:30 | Q&A Session |
| 1:00 | Lunch ‑ On your own |
| AFTERNOON SESSION: ONCOFERTILITY SEMINAR Moderator: Karen Fasciano, PsyD | |
| 2:00 | Fertility for Women after Cancer Elizabeth Ginsburg, MD |
| 2:30 | Fertility for Men after Cancer Kevin Loughlin, MD |
| 3:00 | The Emotional Side of Infertility after Cancer Karen Fasciano, PsyD |
| 3:30 | Q&A Session |
| 4:00 | Closing Remarks Kenneth D. Miller, MD |
November 6‑8, 2009
Dana‑Farber Cancer Institute, Boston, Massachusetts
Offered by: Dana‑Farber Cancer Institute
Course Director: Kenneth D. Miller, MD
Co‑Directors Larissa Nekhlyudov, MD, MPH and Richard Boyajian, NP
Call for Abstracts - due October 5 to Kaitlin_Ostrander@DFCI.HARVARD.EDU
Early Registration ends October 15
| NOVEMBER 6, 2009 | |
|---|---|
| MORNING SESSION: THE EMOTIONAL JOURNEY OF SURVIVORSHIP Moderator: Kenneth D. Miller, MD | |
| 8:30 | Opening Remarks Kenneth D. Miller, MD |
| 8:45 | Seasons of Survivorship Kenneth D. Miller, MD |
| 9:15 | The Emotional Journey of Survivorship‑An Overview Harriet K. Berman, PhD |
| 9:455 | Fear of Recurrence Amy Grose, LICSW |
| 10:15 | Coffee Break |
| 10:30 | Children of Cancer Survivors Vaughn Mankey, MD |
| 11:00 | “We’re in this Together” Co‑Survivors: Spouses and Partners of Cancer Survivors Jane Bausch, LICSW |
| 11:30 | Panel Discussion: The Emotional Journey of Survivorship Amy Grose, LICSW |
| 12:00 | Q&A Session |
| 12:30 | Lunch ‑ On your own |
| AFTERNOON SESSION: CAN WE REDUCE THE RISK OF SECOND CANCERS? Moderator: Julie Silver, MD | |
| 1:30 | Exercise and Cancer Jennifer Ligibel, MD |
| 2:00 | Fighting Cancer with a Fork: Nutrition and Cancer Jeffrey Meyerhardt, MD, MPH |
| 2:30 | Smoking and Smoking Cessation Elyse Park, PhD, MPH |
| 3:00 | Coffee Break |
| 3:15 | Second and Secondary Cancers Andrea Ng, MD, MPH |
| 3:45 | Cancer Rehabilitation Julie Silver, MD |
| 4:15 | Panel Discussion: Lifestyle in Cancer Survivorship Julie Silver, MD |
| 4:45 | Q&A Session |
| 5:00 | Dinner ‑ On your own / Optional Poster Session |
| EVENING SESSION: PRIMARY CARE SYMPOSIUM Moderator: Larissa Nekhlyudov, MD, MPH | |
| 6:30 | Who Will Care for Cancer Survivors? Lawrence N. Shulman, MD |
| 7:15 | What Is Optimal Care for Cancer Survivors: Primary Care, Oncologists, or Both? Larissa Nekhlyudov, MD, MPH |
| 7:45 | The Nuts and Bolts Approach to Survivorship Care: Richard Boyajian, NP Risk Assessment and Care Planning Karen Sommer, NP Psychosocial Counseling Amy Grose, LICSW Nutrition Counseling Stephanie Meyers, MS, RD, LDN |
| 9:00 | Q&A Session |
| NOVEMBER 7, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR WOMEN Moderator: Ann Partridge, MD, MPH | |
| 8:30 | Sexuality and Intimacy Jennifer Potter, MD |
| 9:00 | Endocrine Issues,Menopause, and Bone Health Jean Mulder, MD |
| 9:30 | Screening after Cancer ‑ Compliance Concerns Susan E. Pories, MD, FACS |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| 10:30 | Gynecologic Issues Sandy Falk, MD |
| 11:00 | Special Survivorship Concerns for Women with Breast Cancer Ann Partridge, MD, MPH |
| 11:30 | Panel Discussion: Women and Survivorship Ann Partridge, MD, MPH |
| 12:00 | Q&A Session |
| 12:15 | Lunch ‑ On your own |
| AFTERNOON SESSION: KEEPING CANCER SURVIVORS HEALTHY Moderator: Lawrence N. Shulman, MD | |
| 1:15 | Medical Issues for Adult Survivors of Childhood Cancer Lisa Diller, MD |
| 1:45 | Pulmonary Issues for Cancer Survivors Gerald Weinhouse, MD |
| 2:15 | Renal Issues after Cancer Therapy Benjamin D. Humphreys, MD, PhD |
| 2:45 | Q&A Session |
| 3:00 | Coffee Break |
| 3:15 | Cardiac Issues for Cancer Survivors Javid Moslehi, MD |
| 3:45 | Oral Health Issues Nathaniel S. Treister, DMD, DMSc |
| 4:15 | Panel Discussion: Keeping Cancer Survivors Healthy Lawrence N. Shulman, MD |
| 4:45 | Q&A Session |
| NOVEMBER 8, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR MEN Moderator: Kenneth D. Miller, MD | |
| 8:30 | Sexual Health for Men after Cancer William Conners, MD |
| 9:00 | Depression and Anxiety in Men after Cancer Frank McCaffrey, LICSW, OSW‑C |
| 9:30 | A Panel of Men Who Are Cancer Survivors Frank McCaffrey, LICSW, OSW‑C |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| MINI‑SEMINAR: MEDICAL ISSUES IN SURVIVORSHIP: MORE ON KEEPING CANCER SURVIVORS HEALTHY Moderator: Kenneth D. Miller, MD | |
| 10:30 | Cognitive Problems “Chemobrain” Mary‑Ellen Meadows, PhD |
| 11:00 | Neurologic Problems Patrick Wen, MD |
| 11:30 | Dermatologic Problems Arturo Saavedra, MD, PhD, MBA |
| 12:00 | Pain and Symptom Management in Cancer Survivors Jane deLima Thomas, MD |
| 12:30 | Q&A Session |
| 1:00 | Lunch ‑ On your own |
| AFTERNOON SESSION: ONCOFERTILITY SEMINAR Moderator: Karen Fasciano, PsyD | |
| 2:00 | Fertility for Women after Cancer Elizabeth Ginsburg, MD |
| 2:30 | Fertility for Men after Cancer Kevin Loughlin, MD |
| 3:00 | The Emotional Side of Infertility after Cancer Karen Fasciano, PsyD |
| 3:30 | Q&A Session |
| 4:00 | Closing Remarks Kenneth D. Miller, MD |
Beth Israel Deaconess Medical Center, Hematology/Oncology Grand Rounds
Speaker: Professor Bernhard Lammle, MD
Topic: "Thrombotic Thrombocytopenic Purpura: A Disease with More Researchers than Patients"
This course will provide gynecologists, primary care physicians, nurse practitioners, and other interested clinicians with an update on developments in diagnosing and treating gynecologic cancers. Attendees will learn about updates in evaluating PAP smears, new approaches for treating gynecologic malignancies, and genetic risk and prevention factors for ovarian cancer.
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education. Harvard Medical School designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For complete course information, and to register, visit: http://www.dfbwcc.org/classes/2009-11-07.html
The HMS Office for Diversity & Community Partnership is pleased to invite you to attend Native American Health Forum - “Diabetes and Health Policy in American Indian Communities” followed by the video: “Unnatural Causes: Bad Sugar”
with Donald Warne, MD, MPH
President and CEO, American Indian Health and Management Policy, LLC
Please see the attached flier for more information.
RSVP by Thursday, October 26, 2009
Beth Israel Deaconess Medical Center, Hematology/Oncology Grand Rounds
Speaker: David E. Fisher, MD, PhD, Massachusetts General Hospital, Chief, Department of Dermatology, Director, Melanoma Program in Medical Oncology, Director, Cutaneous Biology Research Center
Presentation: "Signaling and Transcriptional Pathways in Melanoma"
“Gene Therapy – Mediated Reversal of Congenital Blindness”
Tufts University School of Medicine is pleased to welcome Jean Bennett, M.D., Ph.D., an internationally recognized leader in retinal gene therapy, as the presenter of the 2009 Jeffrey M. Isner, M.D. Endowed Memorial Lectureship. Dr. Bennett’s ground-breaking research in gene transfer approaches established the scientific underpinnings which made it possible to test the first potential definitive retinal gene therapy treatment for patients with blinding retinal degenerations. Please join us for this inspiring presentation!
Speaker:
Jean Bennett, M.D., Ph.D.
F.M. Kirby Professor and Vice Chair of Research
Department of Ophthalmology
Professor, Cell and Developmental Biology
University of Pennsylvania
Scientist, Center for Cellular and Molecular Therapeutics
The Children’s Hospital of Philadelphia
4th Annual Jeffrey M. Isner Endowed Memorial Lectureship
Wednesday, November 4, 2009
4 pm
Behrakis Auditorium
Tufts University School of Medicine
Reception to follow
RSVP to Karolina Wrobel; karolina.wrobel@tufts.edu
Tufts University School of Medicine
Office of Alumni Relations
p: 617.636.6770
Epidemiology Seminar Series
Wednesday, November 18, 2009
12:30 pm
Speaker: Immaculata De Vivo, M.P.H., Ph.D
Associate Professor, Department of Medicine, Harvard Medical School
Boston, MA
"Telomeres and Chronic Disease"
@ 12:30 PM
Kresge Building Room 502
677 Huntington Avenue
Boston, Massachusetts
Sponsored by DF/HCC and the Epidemiology Department at HSPH
Programs presented include:
“Nab-paclitaxel®; ABI-008 (nab®-docetaxel); ABI-009 (nab®-rapamycin); ABI-010 (nab®-17AAG - Hsp90 inhibition); ABI-011 (nab®-dual mechanism inhibitor - microtubule destabilization and topo-1 inhibition) and ABI-0013 (nab®-novel taxane).
"Cancer Serology Comes of Age: Proteomics for Cancer Detection and Prognosis"
Karen Anderson, M.D. , Ph.D.
Instructor, Department of Medicine - HMS
Instructor in Medicine, Hematology/Oncology - DFCI
Tuesday, November 3, 2009
5:30pm SM308/309 DFCI
Friday, November 6, 2009
10:30 am - 11:30 am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
CONFERENCE TITLE: Improved Adoptive Immunotherapy for EGFRvIII expressing glioblastoma through '3rd generation' chimeric receptor engineered T cells
Ayguen Sahin, PhD
Instructor at Harvard Medical School
MGH-HMS Center for Nervous System Repair
Department of Neurosurgery
Developing World:
Meeting the Unforeseen Challenge
to Women, Health and Equity
November 3-5, 2009
Longwood Medical Area
Register at:
www.hsph.harvard.edu/breastandhealth/
Open to the Harvard Community
Questions? breastandhealth@harvard.edu
Please note: If you registered previously, prior to the posting of workshops on the website, kindly re-register and sign-up for the workshop(s) that you would like to attend. These are now included in the registration process.
Dates & Venues: November 3-5, 2009, Longwood Medical Area, Boston, Massachusetts
Tuesday, November 3 (13:00-19:30)
Brigham and Women's Hospital, 1620 Tremont Street, Roxbury Crossing, MA
Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA
Pre-conference workshops. Pre-registration is required. Seating is limited.
Wednesday, November 4 (full day beginning at 9:00)
Joseph B. Martin Conference Center, Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115.
Plenary sessions and lunch event. Pre-registration is recommended (but not required) for plenary sessions. Pre-registration is required for the lunch. Seating is limited for opening session, keynote and lunch.
Thursday, November 5 (full day beginning at 9:00)
Dana-Farber Cancer Institute, Jimmy Fund Auditorium
44 Binney St. Boston, MA 02115.
Plenary sessions and workshops. Pre-registration is recommended (but not required) for plenary sessions. Pre-registration is required for workshops. Seating is limited.
Conference Overview:
The conference will be opened by Jeffrey Flier, Dean of the Faculty of Medicine at Harvard Medical School; by Felicia Knaul, Director of the Harvard Global Equity Initiative; by Her Excellency Madam Tobeka Madiba Zuma, First Lady, The Republic of South Africa and Vice Chairperson, Forum of African First Ladies Against Breast & Cervical Cancer; by HRH Princess Dina Mired, Director General, King Hussein Cancer Foundation and Honorary Chairperson, National Breast Cancer Committee, Hashemite Kingdom of Jordan; by Lawrence Shulman, Chief Medical Officer and Senior Vice President for Medical Affairs, Dana-Farber Cancer Institute; and by Drew Gilpin Faust, President of Harvard University. The opening keynote address will be delivered by Amartya Sen, Nobel Laureate in Economics, and Thomas W. Lamont University Professor and Professor of Economics and Philosophy of Harvard University. A video address will be delivered by Margaret Chan, Director-General, World Health Organization.
Confirmed speakers include: Ambassador Nancy G. Brinker, Susan G. Komen for the Cure and World Health Organization; Julio Frenk, Dean, Harvard School of Public Health, T & G Angelopoulos Professor of Public Health and International Development at the Harvard School of Public Health and Harvard Kennedy School, and former Minister of Health of Mexico; Lawrence Shulman, Chief Medical Officer and Senior Vice President for Medical Affairs, Dana-Farber Cancer Institute; Geeta Rao Gupta, President, International Center for Research on Women; Marina A. Njelekela, Chairperson, Medical Women's Association of Tanzania; Alejandro Mohar Betancourt, Director, National Cancer Institute of Mexico; Peter Piot, Director, Institute for Global Health, Imperial College London and former Executive Director, UNAIDS; and, John Seffrin, CEO, American Cancer Society.
Conference Steering Committee:
Flavia Bustreo, MD
Director, Partnership for Maternal Newborn and Child Health-Secretariat
World Health Organization
Alessandra Durstine
Vice President of Regional Strategies, International Affairs Department
American Cancer Society
Paul Farmer, MD, PhD
Presley Professor and Chair, Department of Global Health and Social Medicine,
Harvard Medical School
Chief, Division of Global Health Equity, Brigham and Women's Hospital
Co-founder, Partners In Health
Julio Frenk, MD, MPH, PhD
Dean, Harvard School of Public Health
T & G Angelopoulos Professor of Public Health and International Development, Harvard School of Public Health and Harvard Kennedy School
Mary Gospodarowicz, FRCPC, FRCR, MD
Professor and Chair, Department of Radiation Oncology, University of Toronto
Medical Director of the Oncology Program and Chief of the Radiation Medicine Program, Princess Margaret Hospital
Julie Gralow, MD
Director of Breast Medical Oncology, Seattle Cancer Care Alliance
Professor, University of Washington School of Medicine
Paula Johnson, MD, MPH
Executive Director, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School
Felicia Marie Knaul, PhD (conference organizer)
Director, Harvard Global Equity Initiative
Associate Professor of Medicine and Social Medicine, Harvard Medical School
Founder, "Cáncer de mama: Tómatelo a Pecho"
Ana Langer, MD
President and Chief Executive Officer, EngenderHealth
Lawrence Shulman, MD
Chief Medical Officer and Sr. Vice-President for Medical Affairs, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Sponsors include (in addition to the institutions represented by the steering committee) Fred Hutchinson Cancer Research Center; Susan G. Komen for the Cure; and International Development Research Center, Canada.
Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors
On behalf of the organizers, we would like to invite you to attend the 9th Frye Halloran Symposium at Massachusetts General Hospital. On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors. We invite you to attend this tuition-free meeting.
Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents.
The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of ‘designer’ drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.We ask that you explore our Website http://fh2009.neurosuite.org for more information. If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org.
Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors
On behalf of the organizers, we would like to invite you to attend the 9th Frye Halloran Symposium at Massachusetts General Hospital. On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors. We invite you to attend this tuition-free meeting.
Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents.
The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of ‘designer’ drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.
We ask that you explore our Website http://fh2009.neurosuite.org for more information. If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org.
Ixempra
Sprycel
Erbitux
Full Development
Ipilimumab
Brivanib
Tanespimycin
XL-184
Exploratory Development
IGF-R Antagonist
VEGF R-2 Adnectin inhibitor (CT-322)
ErbB/VEGF inhibitor
Anti-CD 137 antibody
Epothilone-Folate
SMO Inhibitor
Cdc7 inhibitor (XL-413)
Anti-CS1 antibody (Elotuzumab)
Adnectin Bispecific inhibitor
RAF Kinase inhibitor (XL-281)
On December 2nd there will be a planning meeting of the DF/HCC Angiogenesis, Invasion and Metastasis Program in Development.
We will discuss future plans, new initiatives, nodal events and ways to increase collaborations. The meeting is open to current members and individuals who may be interested in joining.
The meeting will be held Wednesday, December 2, at 4 pm in the Cannon Room, Building C of HMS.
Please RSVP to Raji Bhat (rgbhat@bidmc.harvard.edu) , if you plan to attend
DFCI/BWH Multidisciplinary Neuro-Oncology Conference Presents:
Chordoma: unlocking the mystery of a baffling disease
Ossama Al-Mefty, MD, FACS
Professor of Neurosurgery
Specialist in Skull Base Surgery
Little Rock, Arkansas
Friday, November 13, 2009
10:30 am - 11:30 am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
*Attendance at this lecture will fulfill requirements for 1 hour of AMA PRA category 1 credit, Harvard Medical School, Department of Continuing Education.*
Please contact Vida Tafoya at vtafoya@partners.org with questions regarding this lecture.
American Association for Cancer Research, Boston Section
Announces the
24th Apffel Memorial Lecture
Thursday, November 19, 2009
3:30-4:30 PM
“Molecular Determinants of Intestinal Differentiation and Tumorigenesis”
Daniel Louvard, Ph.D.
Director, Curie Institute Research Center
Professor, Pasteur Institute
Paris, France
Rabkin Board Room
Shapiro Clinical Center, 10th Floor
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA
Light reception will follow lecture
Parking
East Campus Main Garage: Located off the main entrance to the medical center's Feldberg Building at 330 Brookline
Avenue; convenient for East Campus buildings. Cashier is located off the lobby of the Feldberg building; customers
pay just before returning to their cars.
The Carl J. Shapiro Clinical Center Garage: Underground garage located on Binney Street, off Longwood Avenue.
Cashier is located on the lobby level of the Shapiro Clinical Center; customers pay just before returning to their cars.
Michael Dyer, Ph.D.
Howard Hughes Medical Institute Early Career Scientist
Member, Department of Development Neurobiology, St. Jude Children's Research Hospital
Retinoblastoma: Bridging Developmental Neurobiology and Cancer Genetics
Tuesday, December 1, 2009
4:00 p.m. - 5:00 p.m.
Folkman (Enders) Auditorium
John F. Enders Research Bldg.
Cardiovascular Seminar Series
Department of Cardiology — Children's Hospital Boston
This conference is supported by the Faye and Karen Sinclair Research Fund for Congenital Heart Disease
BWH/DFCI Multidisciplinary Neuro-Oncology Conference Presents:
Pursuing potential biomarkers of response and resistance to antiangiogenic therapy: Which ones and why?
Dan G. Duda, DMD, PhD
Assistant Professor of Radiation Oncology
Edwin L. Steele Laboratory for Tumor Biology
Department of Radiation Oncology
Massachusetts General Hospital
Harvard Medical School
Friday, November 20, 2009
11:00am - 11:45am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
TWO REPRINTS ARE AVAILABLE FOR THIS LECTURE:
1. Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for
Solid Cancers
2. Biomarkers of response and resistance to antiangiogenic therapy
Please refer to website for reprints: http://www.dfhcc.harvard.edu/
(You may access the reprint by clicking on the DF/HCC calendar icon followed by the DFCI/BWH Multidisciplinary Neuro-Oncology Conference link.)
*Attendance at this lecture will fulfill requirements for 1 hour of AMA PRA category 1 credit, Harvard Medical School, Department of Continuing Education.*
UPCOMING CONFERENCES:
November 20, 2009
CONFERENCE TITLE: Pursuing potential biomarkers of response and resistance to antiangiogenic therapy: Which ones and why?
Dan G. Duda, DMD, PhD
Assistant Professor of Radiation Oncology
Edwin L. Steele Laboratory for Tumor Biology
Department of Radiation Oncology
Massachusetts General Hospital
Harvard Medical School
November 27, 2009
NO CONFERENCE
(Thanksgiving weekend)
December 4, 2009
CONFERENCE TITLE: A synthetic glioma vaccine based on genomic
Peptides
Samuel Bogoch, MD, PhD
Chairman, Foundation for Research on the
Nervous System
Dana-Farber Cancer Institute
Program in Cancer Chemical Biology
Seminar Series
“Biomaterials and biotechnology: From the discovery of
angiogenesis inhibitors to the development of controlled drug
delivery systems and the foundation of tissue engineering”
Robert S. Langer, Sc.D.
David H. Koch Institute Professor
Massachusetts Institute of Technology
Chemical Engineering Department
Cambridge, MA
Abstract
Research starting with the development of novel delivery systems for
macromolecules is discussed. For example, new drug delivery technologies
including nanoparticles and nanotechnology promise to create new treatments
for cancer and other illnesses. They have also been used as essential parts of
the assays used to isolate angiogenesis inhibitors. The creation of new
biomaterials is also discussed. Furthermore, by combining mammalian cells,
including stem cells, with synthetic polymers, new approaches for engineering
tissues are being developed that may someday help repair various tissues.
Thursday, November 19th, 2009
5:00pm
Jimmy Fund Auditorium
Host: Gregory Verdine, Ph.D.
DFCI Tel: 617-632-4502
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer CenterDesignated by the National Cancer Institute